Drug Trial Radar · NCT06577090
Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo
Last checked: Nov 19, 2026Latest source record: Jan 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
136
Actual
Start
Aug 22, 2024
Primary completion
Nov 20, 2026
Study completion Feb 28, 2027
Sponsor
- Lead sponsor
- Skye Bioscience, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 29, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a proof-of-concept study to assess the safety and efficacy of Nimacimab Injection compared to an active and placebo injection control.
Conditions
- Obesity
Interventions
Nimacimab injectionBiological
Nimacimab injection 200 mg
Nimacimab placebo injectionBiological
matching nimacimab placebo injection
semaglutide injectionCombination product
semaglutide injection 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg + nimacimab 200 mg
Nimacimab 300 mg injectionBiological
Nimacimab injection 300 mg
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent change in body weight (main study)Time frame: From Baseline to Week 26
- Nature, frequency and severity of AEs (study extension)Time frame: Baseline through Week 38 of study extension (approximately 10 months of participation)
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Pinnacle Research Group
Anniston, Alabama
Diablo Clinical Research, Inc.
Walnut Creek, California
Chase Medical Research, LLC
Waterbury, Connecticut
ACCEL Research Sites
Atlanta, Georgia
Center for Advanced Research & Education
Gainesville, Georgia
L-MARC Research Center
Louisville, Kentucky
Be Well Clinical Studies
Lincoln, Nebraska
Palm Research Center
Las Vegas, Nevada
ActivMed Practices & Research
Portsmouth, New Hampshire
Weill Cornell Medicine
New York, New York
Accellacare of Wilmington
Wilmington, North Carolina
Lillestol Research, LLC
Fargo, North Dakota
Velocity Clinical Research, Dallas
Dallas, Texas
Be Well Clinical Studies
Round Rock, Texas
Charlottesville Medical Research
Charlottesville, Virginia
Rainier Clinical Research Center
Renton, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.